{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:26:28Z","timestamp":1791195988709,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13014-018-0966-5","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T12:21:32Z","timestamp":1518178892000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma"],"prefix":"10.1186","volume":"13","author":[{"given":"Yasuhiro","family":"Hirano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakatsu","family":"Onozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehiro","family":"Hojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Motegi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadatomo","family":"Zenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Moriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenobu","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Akimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,9]]},"reference":[{"key":"966_CR1","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1200\/JCO.2003.12.095","volume":"21","author":"N Ando","year":"2003","unstructured":"Ando N, Iizuka T, Ide H, Ishida K, Shinoda M, Nishimaki T, et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan clinical oncology group study--JCOG9204. J Clin Oncol. 2003;21:4592\u20136.","journal-title":"J Clin Oncol"},{"key":"966_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1245\/s10434-011-2049-9","volume":"19","author":"N Ando","year":"2012","unstructured":"Ando N, Kato H, Igaki H, Shinoda M, Ozawa S, Shimizu H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68\u201374.","journal-title":"Ann Surg Oncol"},{"key":"966_CR3","doi-asserted-by":"crossref","unstructured":"Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M. Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 2000;232:225-232.","DOI":"10.1097\/00000658-200008000-00013"},{"key":"966_CR4","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ijrobp.2010.06.033","volume":"81","author":"K Kato","year":"2011","unstructured":"Kato K, Muro K, Minashi K, Ohtsu A, Ishikura S, Boku N, et al. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). Int J Radiat Oncol Biol Phys. 2011;81:684\u201390.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"966_CR5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0360-3016(98)00047-9","volume":"41","author":"U Isacsson","year":"1998","unstructured":"Isacsson U, Lennernas B, Grusell E, Jung B, Montelius A, Glimelius B. Comparative treatment planning between proton and x-ray therapy in esophageal cancer. Int J Radiat Oncol Biol Phys. 1998;41:441\u201350.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"966_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1269\/jrr.42.79","volume":"42","author":"K Ando","year":"2001","unstructured":"Ando K, Furusawa Y, Suzuki M, Nojima K, Majima H, Koike S, et al. Relative biological effectiveness of the 235 MeV proton beams at the National Cancer Center Hospital east. J Radiat Res. 2001;42:79\u201389.","journal-title":"J Radiat Res"},{"key":"966_CR7","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0360-3016(03)00585-6","volume":"57","author":"S Hironaka","year":"2003","unstructured":"Hironaka S, Ohtsu A, Boku N, Muto M, Nagashima F, Saito H, et al. Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T2\u20133Nany M0 squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys. 2003;57:425\u201333.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"966_CR8","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1093\/jjco\/hyp069","volume":"39","author":"H Kato","year":"2009","unstructured":"Kato H, Sato A, Fukuda H, Kagami Y, Udagawa H, Togo A, et al. A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan clinical oncology group study (JCOG9708). Jpn J Clin Oncol. 2009;39:638\u201343.","journal-title":"Jpn J Clin Oncol"},{"key":"966_CR9","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1001\/jama.281.17.1623","volume":"281","author":"JS Cooper","year":"1999","unstructured":"Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA Jr, Al-Sarraf M, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation therapy oncology group. JAMA. 1999;281:1623\u20137.","journal-title":"JAMA"},{"key":"966_CR10","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/jjco\/hyt048","volume":"43","author":"K Kato","year":"2013","unstructured":"Kato K, Nakajima TE, Ito Y, Katada C, Ishiyama H, Tokunaga SY, et al. Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for stage II-III esophageal carcinoma. Jpn J Clin Oncol. 2013;43:608\u201315.","journal-title":"Jpn J Clin Oncol"},{"key":"966_CR11","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1200\/JCO.2003.03.055","volume":"21","author":"S Ishikura","year":"2003","unstructured":"Ishikura S, Nihei K, Ohtsu A, Boku N, Hironaka S, Mera K, et al. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol. 2003;21:2697\u2013702.","journal-title":"J Clin Oncol"},{"key":"966_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00535-006-1771-8","volume":"41","author":"Y Kumekawa","year":"2006","unstructured":"Kumekawa Y, Kaneko K, Ito H, Kurahashi T, Konishi K, Katagiri A, et al. Late toxicity in complete response cases after definitive chemoradiotherapy for esophageal squamous cell carcinoma. J Gastroenterol. 2006;41:425\u201332.","journal-title":"J Gastroenterol"},{"key":"966_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ijrobp.2008.10.075","volume":"75","author":"M Morota","year":"2009","unstructured":"Morota M, Gomi K, Kozuka T, Chin K, Matsuura M, Oguchi M, et al. Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2009;75:122\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"966_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11604-011-0002-2","volume":"30","author":"G Kumar","year":"2012","unstructured":"Kumar G, Rawat S, Puri A, Sharma MK, Chadha P, Babu AG, et al. Analysis of dose-volume parameters predicting radiation pneumonitis in patients with esophageal cancer treated with 3D-conformal radiation therapy or IMRT. Jpn J Radiol. 2012;30:18\u201324.","journal-title":"Jpn J Radiol"},{"key":"966_CR15","doi-asserted-by":"publisher","first-page":"556","DOI":"10.7326\/0003-4819-151-8-200910200-00145","volume":"151","author":"T Terasawa","year":"2009","unstructured":"Terasawa T, Dvorak T, Ip S, Raman G, Lau J, Trikalinos TA. Systematic review: charged-particle radiation therapy for cancer. Ann Intern Med. 2009;151:556\u201365.","journal-title":"Ann Intern Med"},{"key":"966_CR16","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ijrobp.2008.05.014","volume":"72","author":"X Zhang","year":"2008","unstructured":"Zhang X, Zhao KL, Guerrero TM, McGuire SE, Yaremko B, Komaki R, et al. Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophageal cancer. Int J Radiat Oncol Biol Phys. 2008;72:278\u201387.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-0966-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T00:34:30Z","timestamp":1549672470000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-018-0966-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,9]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["966"],"URL":"https:\/\/doi.org\/10.1186\/s13014-018-0966-5","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,9]]},"assertion":[{"value":"24 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"23"}}